Dimensional Fund Advisors LP recently announced the acquisition of new stake in Barclays plc ADR (NYSE:BCS). The institutional investor has increased its shareholding in the Financial company by 5.97% to 19.05 million shares with purchase of 1.07 million shares. This fresh investment now brings its stake to 0.51% valued currently at $137.51 million. In addition, Arrowstreet Capital LP raised its holdings by 1.06 million to 17.47 million shares. And Northern Trust Investments, Inc. has lifted its position by 5.03% or 0.21 million shares – to 4.41 million shares.
With over 13.76 million Barclays plc ADR (BCS) shares trading Friday and a closing price of $7.88 on the day, the dollar volume was approximately $108.43 million. The shares have shown a positive half year performance of 0.25% and its price on 12/29/23 lost nearly -0.13%. Currently, there are 3.96B common shares owned by the public and among those 3.58B shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 17 analysts who have offered their price forecasts for BCS have a consensus price objective of $2.05. The analysts have set the share’s price value over the next 12 months at a high of $2.90 and a low of $1.41. The average price target is 22.59% above its recent price level and a downside to the estimated low will see the stock lose -458.87% over that period. But a downside of -171.72% will see the stock hit the forecast high price target while median target price for the stock is $2.00.
The top 3 mutual fund holders in Barclays plc ADR are DFA International Value Series, Dimensional International Value E, and DFA International Core Equity Por. DFA International Value Series owns 5.64 million shares of the company’s stock, all valued at over $40.72 million. The company sold -1.53 million shares recently to bring their total holdings to about 0.15% of the shares outstanding. DFA International Core Equity Por now owns shares totaling to 0.08% of the shares outstanding.
However, the script later moved the day high at 7.91, down -0.13%. The company’s stock has a 5-day price change of 1.55% and 1.16% over the past three months. BCS shares are trading 1.03% year to date (YTD), with the 12-month market performance up to 1.81% higher. It has a 12-month low price of $6.23 and touched a high of $9.44 over the same period. BCS has an average intraday trading volume of 12.91 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.23%, 10.98%, and 4.81% respectively.
Institutional ownership of Barclays plc ADR (NYSE: BCS) shares accounts for 3.61% of the company’s 3.96B shares outstanding. Mutual fund holders own 0.57%, while other institutional holders and individual stakeholders account for 3.04% and — respectively.
It has a market capitalization of $29.79B and a beta (3y monthly) value of 1.46. The company has a debt-to-equity ratio at 3.46. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.26% over the week and 1.86% over the month.
The lowest estimate earnings-per-share for the quarter is $0 while analysts give the company a high EPS estimate of $0. Earnings per share for the fiscal year are expected to decrease by -0.15%, and 6.36% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 17 brokerage firm advisors rate Barclays plc ADR (BCS) as a “Strong Buy” at a consensus score of 1.94. Specifically, 10 Wall Street analysts polled rate the stock as a buy, while 5 of the 17 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the BCS, a number of firms have released research notes about the stock. BofA Securities stated their Underperform rating for the stock in a research note on October 26, 2023, with the firm’s price target at $8.77-$7.31.
